Renaissance Technologies
QNRX

Renaissance Technologies’s Quoin Pharmaceuticals QNRX Stock Holding History

Renaissance Technologies’s Portfolio QNRX Stock Details QNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,803
Closed -$86.6K – 3766
2024
Q4 		$86.6K Buy
3,803
+2,698
+244% +$61.9K ﹤0.01% 3306
2024
Q3 		$19.1K Buy
1,105
+128
+13% +$2.69K ﹤0.01% 3429
2024
Q2 		$19.8K Sell
977
-352
-26% -$8.94K ﹤0.01% 3384
2024
Q1 		$44K Buy
+1,329
New +$131K ﹤0.01% 3503
2023
Q2 		– Sell
-33
Closed -$7K – 4207
2023
Q1 		$7K Buy
+33
New +$16.1K ﹤0.01% 3902
2022
Q3 		– Sell
-12
Closed -$29K – 4343
2022
Q2 		$29K Buy
12
+2
+20% +$7.96K ﹤0.01% 4082
2022
Q1 		$67K Sell
10
-6
-38% -$44.8K ﹤0.01% 3856
2021
Q4 		$152K Buy
16
+9
+129% +$387K ﹤0.01% 3602
2021
Q3 		$670K Buy
7
+1
+17% +$97.4K ﹤0.01% 2759
2021
Q2 		$433K Hold
6
– – ﹤0.01% 3016
2021
Q1 		$418K Sell
6
-1
-14% -$69.8K ﹤0.01% 2979
2020
Q4 		$320K Sell
7
-4
-36% -$174K ﹤0.01% 3010
2020
Q3 		$466K Sell
11
-2
-15% -$116K ﹤0.01% 2833
2020
Q2 		$868K Buy
13
+4
+44% +$231K ﹤0.01% 2611
2020
Q1 		$275K Buy
9
+4
+80% +$189K ﹤0.01% 3009
2019
Q4 		$227K Buy
5
+1
+25% +$51.3K ﹤0.01% 3162
2019
Q3 		$183K Buy
4
+1
+33% +$54.3K ﹤0.01% 3170
2019
Q2 		$171K Buy
3
+2
+200% +$158K ﹤0.01% 3330
2019
Q1 		$148K Buy
+1
New +$179K ﹤0.01% 3252

Other funds holding QNRX

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Renaissance Technologies's QNRX Position: Q1 2025 in Review

Renaissance Technologies sold out of Quoin Pharmaceuticals (QNRX) in Q1 2025, closing a stake of 3,803 shares — an estimated $86.6K sold.

Renaissance Technologies first reported a position in QNRX in Q1 2019 and held it in 19 quarters. The position peaked at $868K in Q2 2020. 9 funds tracked by Wall St. Rank hold QNRX as of Q1 2025.

  • Renaissance Technologies reported no remaining Quoin Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Renaissance Technologies sold 3,803 Quoin Pharmaceuticals shares in Q1 2025, an estimated $86.6K.
  • Renaissance Technologies first reported a position in Quoin Pharmaceuticals in Q1 2019 and held it in 19 quarters.
  • Renaissance Technologies's Quoin Pharmaceuticals position peaked at $868K in Q2 2020.
  • 9 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q1 2025.

Based on Renaissance Technologies's 13F filing for Q1 2025, filed 14 May 2025.